![PDF) Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis PDF) Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis](https://www.researchgate.net/publication/281782570/figure/fig5/AS:339870556934158@1458042863768/Flow-Chart-of-Study-Search-and-Selection_Q320.jpg)
PDF) Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
Mode of Action of Trimetazidine and Other New Metabolic Agents in the Treatment of Ischemic Heart Disease
![Figure 1 from Focus on Vastarel MR Anti-ischemic cardioprotection with trimetazidine | Semantic Scholar Figure 1 from Focus on Vastarel MR Anti-ischemic cardioprotection with trimetazidine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5027210738266cd35c1451359d0241c7d36bb19f/3-Figure1-1.png)
Figure 1 from Focus on Vastarel MR Anti-ischemic cardioprotection with trimetazidine | Semantic Scholar
![Evidence for the existence of [3H]‐trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore - Morin - 1998 - British Journal of Pharmacology - Wiley Online Library Evidence for the existence of [3H]‐trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore - Morin - 1998 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/3969e191-f73f-48b3-85ed-a1cdd4973c54/bph_1385_f1.gif)
Evidence for the existence of [3H]‐trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore - Morin - 1998 - British Journal of Pharmacology - Wiley Online Library
![Trimetazidine as cardioplegia addictive without pre-treatment does not improve myocardial protection: study in a swine working heart model Trimetazidine as cardioplegia addictive without pre-treatment does not improve myocardial protection: study in a swine working heart model](http://www.scielo.br/img/revistas/rbccv/v23n2/en_a12fig05.gif)
Trimetazidine as cardioplegia addictive without pre-treatment does not improve myocardial protection: study in a swine working heart model
![PDF] The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent. | Semantic Scholar PDF] The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7fa903a6758bfd07861bdca93df80a6c8a6d7c8c/2-Table1-1.png)
PDF] The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent. | Semantic Scholar
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of
![Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure - International Journal of Cardiology Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2041004645/2054947132/gr1.jpg)